US Says 2 Indian Nationals Indicted In Counterfeit Ozempic Smuggling Scheme
One of the defendants, Swapnadip Roy, pleaded not guilty after being extradited from Italy while the other, Vicky Ramancha, remains at large, the department said.
Recommended For YouBetween July 2023 and April 2024, Roy and Ramancha allegedly obtained counterfeit Ozempic in China and sold it to US distributors at discounted prices, it said.
A legal representative for Roy did not immediately respond to a request for comment. One for Ramancha was not immediately available.
The counterfeit medication included packaging, inserts and labels allegedly meant to convince purchasers that they were receiving authentic Ozempic, the popular weight-loss drug that can cost hundreds of dollars per month for patients.
"The scheme continued even after the FDA seized some of the counterfeit Ozempic in December 2023 and issued a public warning regarding the products," the Justice Department said.
Roy and Ramancha were charged with smuggling and selling counterfeit drugs, conspiracy to commit smuggling and to defraud the United States. They face up to 71 years in prison if convicted.
ALSO READ- India seizes suspected fake Mounjaro pens, says raw materials sourced from Alibaba India warns of misuse risk from cheap weight-loss jabs Are Ozempic, Mounjaro, other weight-loss drugs covered by insurance in the UAE?
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment